FDA Warns LA-Based Medical Food Company for Clinical Trial Without an IND
By Zachary Brennan -
Published 18 April 2017
The US Food and Drug Administration (FDA) warning letter released Tuesday says that Los Angeles-based Targeted Medical Pharma ran a clinical investigation of a medical food without first submitting an investigational new drug (IND) application to the agency.
Categories: News, US, FDA, Clinical, Compliance, Crisis management, Nutritional and dietary supplements, Research and development
Tags: warning letter, LA medical foods, medical food clinical trial